Arrhythmias & electrophysiology

Remote Screening for Asymptomatic Atrial Fibrillation: The AMALFI Randomized Clinical Trial

JAMAPublished Randomised controlled trial

Primary resultResult — go to the resultRatio of proportions 1.26 95% CI 1.02–1.57

Authors' conclusion

In this remote randomized clinical trial, mail-based AF screening with an ECG patch in older patients at moderate to high risk of stroke led to a modest long-term increase in AF diagnosis at 2.5 years.

Study context

Population
Adults ≥65 years with CHA2DS2VASc ≥3 (men) or ≥4 (women), no previous atrial fibrillation (AF) or atrial flutter, UK primary care
Participants
5,040 adults
Comparison
Mail-based electrocardiogram (ECG) patch AF screening vs usual care
  • Interventionn = 2,520
  • Controln = 2,520reference
Primary endpoint
Proportion with AF recorded in primary care records
Follow-up
2.5 years postrandomization
Methodological detailsparallel-group, unblinded, remote, 27 UK primary care practices
  • Parallel-group
  • Unblinded
  • Remote
  • 27 UK primary care practices

Primary result

As reported in the abstract

2.5 years

Ratio of proportions

1.26

95% CI 1.02–1.57

P = 0.03

Events by treatment group

Further findings

Mean, months

OutcomeInterventionControlDifference (months) (95% CI)P value
Mean exposure to oral anticoagulation (exploratory) · 2.5 years1.63 (95% CI 1.50–1.76)1.14 (95% CI 1.01–1.26)0.50 (0.24–0.75)P < 0.001
OutcomeInterventionControlRate ratio (95% CI)P value
Stroke (exploratory)2.7%2.5%1.08 (0.76–1.53)

AF detected by patch

AF detected by patch, participants (%)
89 (4.2%)
Of these, AF burden less than 10%
55%
  • 2126 participants (84.4%) wore and returned the patch

AF record, prespecified subgroups

Consistent results in prespecified subgroups

Original publication

Remote Screening for Asymptomatic Atrial Fibrillation: The AMALFI Randomized Clinical Trial. JAMA. Published 21 October 2025. doi:10.1001/jama.2025.15440

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.